Medication reconciliation on discharge in a tertiary care Riyadh Hospital: An observational study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 20 05 2021
accepted: 22 02 2022
entrez: 15 3 2022
pubmed: 16 3 2022
medline: 4 5 2022
Statut: epublish

Résumé

The purpose of this study was to assess the frequency and characteristics of discharge medication discrepancies as identified by pharmacists during discharge medication reconciliation. We also attempted to identify the factors that influence the occurrence of drug discrepancies during medication reconciliation. From June to December 2019, a prospective study was performed at the cardiac center of King Fahad Medical City (KFMC), a tertiary care hospital in Riyadh. The information from discharge prescriptions as compared to the medication administration record (MAR), medication history in the cortex system, and the patient home medication list collected from the medication reconciliation form on admission. The study included all adult patients discharged from KFMC's cardiac center. These participants comprised 776 patients, 64.6 percent of whom were men and 35.4 percent of whom were women. Medication discrepancies were encountered in 180 patients (23.2%) out of 776 patients. In regards to the number of discharged medications, 651(83.9%) patients had ≥ 5 medications. Around, 174 (73.4%) discrepancies were intentional, and 63 (26.6%) were unintentional discrepancies. The risk of unintentional medication discrepancy was increased with an increasing number of medications (P-value = 0.008). One out of every four cardiac patients discharged from our hospital had at least one medication discrepancy. The number of drugs taken and the number of discrepancies was found to be related. Necessary steps should be taken to reduce these discrepancies and improve the standard of care.

Identifiants

pubmed: 35290378
doi: 10.1371/journal.pone.0265042
pii: PONE-D-21-16702
pmc: PMC8923456
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0265042

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

BMC Med Inform Decis Mak. 2016 Aug 22;16:112
pubmed: 27549581
Arch Intern Med. 2009 Nov 23;169(21):2003-10
pubmed: 19933963
Ann Pharmacother. 2008 Oct;42(10):1373-9
pubmed: 18780806
Int J Clin Pharm. 2018 Oct;40(5):1154-1164
pubmed: 29754251
PLoS One. 2021 Jun 23;16(6):e0253588
pubmed: 34161388
Arch Intern Med. 1993 Aug 23;153(16):1863-8
pubmed: 8250647
J Am Med Inform Assoc. 1996 May-Jun;3(3):234-44
pubmed: 8723614
Integr Pharm Res Pract. 2020 Oct 13;9:195-203
pubmed: 33117666
Am J Health Syst Pharm. 2009 Dec 1;66(23):2126-31
pubmed: 19923314
Br J Clin Pharmacol. 2011 Mar;71(3):449-57
pubmed: 21284705
Saudi Pharm J. 2011 Oct;19(4):263-7
pubmed: 23960767
Int J Clin Pharm. 2011 Jun;33(3):501-11
pubmed: 21442286
Saudi Pharm J. 2017 Nov;25(7):1082-1085
pubmed: 29158719
Pharmacotherapy. 1997 Jan-Feb;17(1):126-32
pubmed: 9017773
Pharm Pract (Granada). 2017 Jan-Mar;15(1):864
pubmed: 28503220

Auteurs

Ahmed S Alanazi (AS)

Pharmaceutical Service Department, Main Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.

Sameh Awwad (S)

The Institute of Pharmaceutical Science (IPS) of University of Veterinary and Animal Sciences, Lahore, Pakistan.

Tahir M Khan (TM)

The Institute of Pharmaceutical Science (IPS) of University of Veterinary and Animal Sciences, Lahore, Pakistan.

Syed Mohammed Basheeruddin Asdaq (SMB)

Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Riyadh, Saudi Arabia.

Yahya Mohzari (Y)

Pharmacy Department, Clinical Pharmacy Section, King Saudi Medical City, Riyadh, Saudi Arabia.

Foz Alanazi (F)

Cardiac Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.

Ahmed Alrashed (A)

Pharmaceutical Service Department, Main Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.

Abdulhakeem S Alamri (AS)

Department of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.
Centre of Biomedical Sciences Research (CBSR), Deanship of Scientific Research, Taif University, Taif, Saudi Arabia.

Walaa F Alsanie (WF)

Department of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.
Centre of Biomedical Sciences Research (CBSR), Deanship of Scientific Research, Taif University, Taif, Saudi Arabia.

Majid Alhomrani (M)

Department of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.
Centre of Biomedical Sciences Research (CBSR), Deanship of Scientific Research, Taif University, Taif, Saudi Arabia.

Mohammed AlMotairi (M)

Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH